← Back to Clinical Trials
Recruiting NCT05776082

NCT05776082 Association of Gestational Cardiovascular Health With Pregnancy Outcomes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05776082
Status Recruiting
Phase
Sponsor Women's Hospital School Of Medicine Zhejiang University
Condition Pregnant Women
Study Type OBSERVATIONAL
Enrollment 5,000 participants
Start Date 2023-03-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex Female only
Min Age 20 Years
Max Age 49 Years
Study Type OBSERVATIONAL
Interventions
Questionnaire survey and specimen collection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 5,000 participants in total. It began in 2023-03-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.

Eligibility Criteria

Inclusion Criteria: * Maternal age: 20-49 years; * Natural conception; * Single pregnancy; * Plan to have routine prenatal examinations and give birth in the research center; Exclusion Criteria: * Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy; * Assisted reproduction; * Multiple pregnancy; * Fetus has a known deformity or genetic defects; * Incomplete clinical data.

Frequently Asked Questions

Who can join the NCT05776082 clinical trial?

This trial is open to female participants only, aged 20 Years or older, up to 49 Years, studying Pregnant Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05776082 currently recruiting?

Yes, NCT05776082 is actively recruiting participants. Visit ClinicalTrials.gov or contact Women's Hospital School Of Medicine Zhejiang University to inquire about joining.

Where is the NCT05776082 trial being conducted?

This trial is being conducted at Hangzhou, China, Taizhou, China, Kigali, Rwanda.

Who is sponsoring the NCT05776082 clinical trial?

NCT05776082 is sponsored by Women's Hospital School Of Medicine Zhejiang University. The trial plans to enroll 5,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology